Loading
companiesCompany
Bikanta
Bikanta tried to use tiny fluorescent diamonds as imaging probes to spot cancer earlier. It went through Y Combinator in 2014 and is no longer operating.
Overview
Bikanta developed fluorescent nanodiamond probes for background-free optical imaging, aiming to improve the signal of medical imaging and diagnostics by up to 100-fold over conventional fluorescence according to its YC profile. Nanodiamonds are bright, photostable and non-toxic and can be functionalised to bind cancer targets. The company is listed as inactive in the YC directory and its website was offline when checked on 2026-09-10; no clinical product was launched. Recorded here as part of the complete map of YC companies that took on cancer.
Headquarters
Berkeley, CA, US
Funding
All startupsWound downYC S14
Investors
Stage
Wound down · Y Combinator Summer 2014
Y Combinator profile
Similar pages
- CompanyNearWave
Shares Optical & fluorescence imaging, Y Combinator and the tag yc.
- CompanyAluna
Shares Y Combinator and the tag yc.
- CompanyMednet (theMednet)
Shares Y Combinator and the tag yc.
- CompanyAlixia
Shares Y Combinator and the tag yc.
- CompanyVelorum Therapeutics
Shares Y Combinator and the tag yc.
- CompanyDelee
Shares Y Combinator and the tag yc.
- CompanyResistanceBio (Viosera Therapeutics)
Shares Y Combinator and the tag yc.
- CompanySerinus Biosciences
Shares Y Combinator and the tag yc.